Tandem Diabetes Care (NasdaqGM:TNDM) has enabled compatibility of its Tandem Mobi automated insulin delivery system with ...

– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible ...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...

Tandem Diabetes Care, Inc. TNDM reported better-than-expected fourth-quarter financial results on Thursday. Tandem Diabetes Care reported quarterly losses of 1 cent per share which beat the analyst ...

Shares of Tandem Diabetes Care (NASDAQ: TNDM) leaped on Friday after the insulin delivery specialist reported significant gains in profitability. By the close of trading, Tandem's stock price was up ...

Tandem Diabetes (TNDM) upsizes $265M 0% convertible notes due 2032 with capped calls, detailing pricing, proceeds and use.

MARKHAM, Ontario--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ ...